support). Subsequently, these public hospitals could continue to offer outpatient and inpatient pharmacy services on a sliding scale according to the patient's ability to pay-holding the line on costs but operating at a much-reduced volume.
With some exceptions, Medicare Part D generally has increased the costs of prescription medications for middle-and upper-class senior citizens as compared with previous insurance coverage (i.e., employee, government, or private insurance). However, low-income patients made significant gains in costs and access to medications. With the available Social Security subsidy, eligible people with low incomes and assets have lower prescription costs, no coverage gaps, and no deductibles.
With a new administration coming soon to Washington, let's root for the gross amending or repeal of Medicare Part D. Moreover, such a return to previous conditions of affordable prescription drugs is warranted-with no coverage gaps, no capitation, expanded generics, and subsidies for lower-income patients. 
